101 related articles for article (PubMed ID: 8735202)
1. The effect of glutaraldehyde adulteration of urine specimens on syva EMIT II drugs-of-abuse assays.
George S; Braithwaite RA
J Anal Toxicol; 1996; 20(3):195-6. PubMed ID: 8735202
[TBL] [Abstract][Full Text] [Related]
2. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay.
Goldberger BA; Caplan YH
Clin Chem; 1994 Aug; 40(8):1605-6. PubMed ID: 8045013
[No Abstract] [Full Text] [Related]
3. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
[TBL] [Abstract][Full Text] [Related]
4. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
[TBL] [Abstract][Full Text] [Related]
5. False-positive postmortem EMIT drugs-of-abuse assay due to lactate dehydrogenase and lactate in urine.
Sloop G; Hall M; Simmons GT; Robinson CA
J Anal Toxicol; 1995; 19(7):554-6. PubMed ID: 8577177
[TBL] [Abstract][Full Text] [Related]
6. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
Hailer M; Glienke Y; Schwab IM; von Meyer L
J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
[TBL] [Abstract][Full Text] [Related]
7. Identification of UrinAid-adulterated urine specimens by fluorometric analysis.
Wu A; Schmalz J; Bennett W
Clin Chem; 1994 May; 40(5):845-6. PubMed ID: 8174265
[No Abstract] [Full Text] [Related]
8. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
[TBL] [Abstract][Full Text] [Related]
9. Decreased signal in Emit assays of drugs of abuse in urine after ingestion of aspirin: potential for false-negative results.
Wagener RE; Linder MW; Valdes R
Clin Chem; 1994 Apr; 40(4):608-12. PubMed ID: 8149618
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and elimination of aspirin-induced interference in Emit II d.a.u. assays.
Linder MW; Valdes R
Clin Chem; 1994 Aug; 40(8):1512-6. PubMed ID: 8044989
[TBL] [Abstract][Full Text] [Related]
11. False-negative results in the immunoassay analysis of drugs of abuse: can adulterants be detected by sample check test?
Matriciani B; Huppertz B; Keller R; Weiskirchen R
Ann Clin Biochem; 2018 May; 55(3):348-354. PubMed ID: 28728424
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Dade Behring Syva EMIT 2000 tacrolimus assay on the Bayer Advia 1650.
Stephen DW; Rooke P; Clark S; Coutts M; Crowe L; Docherty D
Ann Clin Biochem; 2003 Nov; 40(Pt 6):697-700. PubMed ID: 14629812
[TBL] [Abstract][Full Text] [Related]
13. Adulterants in Urine Drug Testing.
Fu S
Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
[TBL] [Abstract][Full Text] [Related]
14. Modification of Emit assay reagents for improved sensitivity and cost effectiveness in the analysis of hemolyzed whole blood.
Asselin WM; Leslie JM
J Anal Toxicol; 1992; 16(6):381-8. PubMed ID: 1293406
[TBL] [Abstract][Full Text] [Related]
15. Numerical analysis of an immunochromatographic test strip reader in abused drugs screening.
Chang YZ; Yao WF; Hsiung KP; Chiou MS; Li HY
J Immunoassay Immunochem; 2012; 33(2):180-94. PubMed ID: 22471608
[TBL] [Abstract][Full Text] [Related]
16. Variation in results of cost-effective EMIT assays on the Cobas-Bio analyser.
Moore FM; Simpson D
Br J Biomed Sci; 1993 Mar; 50(1):57-9. PubMed ID: 8032295
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of DRI drug-of-abuse reagents on the Hitachi 911.
Haver V; Black D; Garbin J
J Anal Toxicol; 1998 Sep; 22(5):403-4. PubMed ID: 9737338
[No Abstract] [Full Text] [Related]
18. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
Korte T; Pykäläinen J; Lillsunde P; Seppälä T
J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
[TBL] [Abstract][Full Text] [Related]
19. Urine drugs of abuse testing at the point-of-care: clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT).
Yang JM; Lewandrowski KB
Clin Chim Acta; 2001 May; 307(1-2):27-32. PubMed ID: 11369333
[TBL] [Abstract][Full Text] [Related]
20. An investigation into the extent of possible dilution of specimens received for urinary drugs of abuse screening.
George S; Braithwaite RA
Addiction; 1995 Jul; 90(7):967-70. PubMed ID: 7663318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
